1 week Ago By Defense World Staff
Prudential Financial Inc. purchased a new position in shares of Accuray Incorporated ( NASDAQ:ARAY – Free Report ) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 21,710 shares of the medical equipment provider’s stock, valued at approximately $43,000.
A number of other institutional investors have also recently added to or reduced their stakes in the company. FMR LLC grew its stake in shares of Accuray by 27.2% during the third quarter.
FMR LLC now owns 582,591 shares of the medical equipment provider’s stock valued at $1,049,000 after acquiring an additional 124,459 shares in the last quarter. BNP Paribas Financial Markets grew its stake in Accuray by 1,650.6% during the 3rd quarter.
BNP Paribas Financial Markets now owns 146,384 shares of the medical equipment provider’s stock valued at $263,000 after purchasing an additional 138,022 shares in the last quarter. State Street Corp increased its holdings in Accuray by 3.8% during the 3rd quarter.
State Street Corp now owns 1,894,287 shares of the medical equipment provider’s stock worth $3,410,000 after purchasing an additional 70,008 shares during the last quarter. Jane Street Group LLC raised its position in shares of Accuray by 26.1% in the 3rd quarter.
Jane Street Group LLC now owns 161,653 shares of the medical equipment provider’s stock valued at $291,000 after purchasing an additional 33,417 shares in the last quarter. Finally, XTX Topco Ltd purchased a new position in shares of Accuray during the 3rd quarter valued at approximately $249,000. Institutional investors and hedge funds own 64.
08% of the company’s stock. Wall Street Analysts Forecast Growth Separately, StockNews.com upgraded shares of Accuray from a “hold” rating to a “buy” rating in a research note on Friday.
Accuray Stock Performance Shares of Accuray stock opened at $1.46 on Friday. The firm has a market cap of $150.
13 million, a PE ratio of -29.20 and a beta of 1.30.
Accuray Incorporated has a 1 year low of $1.40 and a 1 year high of $2.95.
The firm’s 50-day simple moving average is $1.93 and its 200-day simple moving average is $1.96.
The company has a debt-to-equity ratio of 3.51, a quick ratio of 0.88 and a current ratio of 1.
62. Accuray ( NASDAQ:ARAY – Get Free Report ) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $0.
02 EPS for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03.
Accuray had a negative return on equity of 9.75% and a negative net margin of 0.96%.
Equities analysts forecast that Accuray Incorporated will post 0.01 earnings per share for the current fiscal year. Accuray Profile ( Free Report ) Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.
It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. Recommended Stories Five stocks we like better than Accuray What is a Secondary Public Offering? What Investors Need to Know JPMorgan is a Buy, if You Can Handle The Volatility How to Choose Top Rated Stocks United States Steel’s Crash: An Unmissable Buying Opportunity What is the NASDAQ Stock Exchange? Rocket Lab Stock: Weathering the Storm, Time for a Comeback? Want to see what other hedge funds are holding ARAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accuray Incorporated ( NASDAQ:ARAY – Free Report ).
Receive News & Ratings for Accuray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accuray and related companies with MarketBeat.com's FREE daily email newsletter ..
